Lupin, Godrej Properties and Cyient to see some action today

01 Jun 2026 Evaluate

Lupin has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g, indicated for the cleansing of the colon as a preparation for colonoscopy in adults. Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g is bioequivalent to the reference listed drug (RLD), Sutab Tablets, 1.479 g/0.225 g/0.188 g of Azurity Pharmaceuticals, Inc. Lupin is the exclusive first-to-file for this product and is eligible for 180-day generic drug exclusivity. This product will be manufactured at Lupin’s Nagpur facility in India.

Godrej Properties (GPL) has won the bid for a 23.2 acres (93,905 sq. mtr.) residential land parcel in DMIC integrated township, Greater Noida, through an e-auction conducted by DMIC Integrated Industrial Township Greater Noida. Godrej Properties plans to develop a residential group housing project on the land parcel, which is expected to offer an estimated revenue potential of over Rs 7,000 crore, comprising premium residential apartments of varied configurations.

Cyient has entered into a definitive agreement to acquire entire stake in Tao Digital Solutions Inc. (Tao Digital), a global digital engineering firm focused on data, product, and AI-led services, with strengths in data platforms, AI-enabled solutions, and cloud services. The transaction is valued at an enterprise value of $218 million (i.e., around 9.5 times of CY27E EBITDA, excluding management incentives, and retention schemes) and expected to be completed on / before September 30, 2026.

Gufic Biosciences has received approval to make further investment in the equity share capital of Saraswat Co-operative Bank by way of subscription to 57,50,800 equity shares having face value of Rs 10 each aggregating to Rs 5.75 crore. The company regularly avails various banking and credit facilities from Saraswat Bank for its business operations and expansion requirements.

Concord Enviro Systems’ material wholly owned subsidiary -- Rochem Separation Systems (India) has secured an order of Rs 126 crore from one of the India’s oldest and most respected integrated steel manufacturers, for the installation of Zero Liquid Discharge (ZLD) systems. The order is to be executed over 18 months. The said order is expected to strengthen the company’s consolidated order book and contribute positively to its revenue visibility over the execution period.

Hardwyn India has received order from M/s Grow Protech LLC (UAE) for supply of Telescopic Channel, Floor Spring, Top Patch, Bottom Patch, Pivot, Handle, Bottom Lock and Pantry Pull out. The broad consideration/value of the order is around $4.55 lakh (around Rs 4.36 crore). The order is to be executed within 150 days after receiving the advance.

NHPC has raised Rs 2,000 crore through issue of Listed Unsecured, Non-Cumulative, Non-Convertible, Redeemable, Taxable 7.67% AI Series Bonds 2041 on private placement basis. The company has issued 2,00,000 bonds having a face value of Rs 1,00,000 each. The bonds carry a coupon rate of 7.67% per annum and have a tenure of 15 years.

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.